Hudson Bay Capital Management LP Uni Qure N.V. Transaction History

Hudson Bay Capital Management LP

$21.9 Billion
Q3 2024

A detailed history of Hudson Bay Capital Management LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 635,500 shares of QURE stock, worth $3.72 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

635,500

Previous 809,117 21.46%

Holding current value

$3.72 Million

Previous $3.62 Million 13.55%

% of portfolio

0.01%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.78 - $10.12 $656,272 - $1.76 Million	-173,617 Reduced 21.46%	635,500 $3.13 Million
Q2 2024 Aug 14, 2024	BUY	$4.39 - $5.43 $1.25 Million - $1.54 Million	284,117 Added 54.12%	809,117 $3.62 Million
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $482,000 - $693,000	100,000 Added 23.53%	525,000 $2.73 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $195,924 - $287,796	34,800 Added 8.92%	425,000 $2.88 Million
Q3 2023 Nov 14, 2023	BUY	$6.71 - $11.83 $1.04 Million - $1.83 Million	155,100 Added 65.97%	390,200 $2.62 Million
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $84,512 - $168,720	7,600 Added 3.34%	235,100 $2.69 Million
Q1 2023 May 16, 2023	BUY	$18.7 - $23.07 $981,750 - $1.21 Million	52,500 Added 30.0%	227,500 $4.58 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $822,800 - $1.02 Million	-44,000 Reduced 20.09%	175,000 $3.52 Million
Q4 2022 Feb 14, 2023	SELL	$18.12 - $27.32 $1.38 Million - $2.08 Million	-76,000 Reduced 25.76%	219,000 $4.96 Million
Q3 2022 Nov 14, 2022	SELL	$16.98 - $25.54 $1.87 Million - $2.81 Million	-110,000 Reduced 27.16%	295,000 $5.53 Million
Q2 2022 Aug 12, 2022	BUY	$13.15 - $20.45 $920,500 - $1.43 Million	70,000 Added 20.9%	405,000 $7.55 Million
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $654,300 - $967,500	45,000 Added 15.52%	335,000 $6.05 Million
Q4 2021 Feb 14, 2022	BUY	$20.24 - $36.01 $607,200 - $1.08 Million	30,000 Added 11.54%	290,000 $6.02 Million
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $751,689 - $1.1 Million	28,900 Added 12.51%	260,000 $8.32 Million
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $1.83 Million - $2.27 Million	61,100 Added 35.94%	231,100 $7.12 Million
Q1 2021 May 14, 2021	BUY	$29.24 - $42.03 $660,824 - $949,878	22,600 Added 15.33%	170,000 $5.73 Million
Q4 2020 Feb 12, 2021	SELL	$35.35 - $50.67 $2.39 Million - $3.43 Million	-67,600 Reduced 31.44%	147,400 $5.33 Million
Q3 2020 Nov 12, 2020	BUY	$35.98 - $47.66 $2.7 Million - $3.57 Million	75,000 Added 53.57%	215,000 $7.92 Million
Q2 2020 Aug 12, 2020	BUY	$45.06 - $67.74 $2.25 Million - $3.39 Million	50,000 Added 55.56%	140,000 $6.31 Million
Q1 2020 May 14, 2020	BUY	$40.01 - $73.97 $1.4 Million - $2.59 Million	35,000 Added 63.64%	90,000 $4.27 Million
Q4 2019 Feb 12, 2020	BUY	$37.13 - $74.62 $2.04 Million - $4.1 Million	55,000 New	55,000 $3.94 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $273M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Bay Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Hudson Bay Capital Management LP with notifications on news.

Account

Hudson Bay Capital Management LP Uni Qure N.V. Transaction History